Andrés José Maria Ferreri
4 clinical trials · Sponsor
◉ Watch Andrés José Maria Ferreri
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP). (NCT07278921) | Andrés José Maria Ferreri | 2025-12-01 |
| Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas. (NCT07181785) | Andrés José Maria Ferreri | 2022-07-12 |
Track Andrés José Maria Ferreri automatically
Every clearance here is in the API, with alerts when new ones post.